Open seminar April 15th 13-17:
New research strategy and organisation in "Helse Sør-Øst"
The "Samarbeidsorganet Helse Sør-Øst RHF - Universitetet i Oslo" invites to a seminar on Tuesday April 15th at 13-17 in the large auditorium at the Rikshospitalet HF.
The theme of the seminar is: "Research in South-Eastern Norway Regional Health Authority - new strategy and organisation".
Final date for registration: April 10th
The seminar is free and open for all.
The main target group is scientific employees/researchers, research coordinators and people working in research administration and management.
Click here for programme and more information (PDF format, in Norwegian).
From major journals, first or last author from the Institute for Cancer Research
Bruland ØS, Larsen RH, Baum RP, Juzeniene A(2023) Editorial: Targeted alpha particle therapy in oncology Front Med (Lausanne), 10, 1165747 DOI 10.3389/fmed.2023.1165747, PubMed 36960341
Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L(2023) Breast cancer patient-derived explant cultures recapitulate in vivo drug responses Front Oncol, 13, 1040665 DOI 10.3389/fonc.2023.1040665, PubMed 36910663
Chauhan SK, Casado RB, Landsverk OJB, Johannessen H, Phung D, Nilsen HR, Sætre F, Jahnsen J, Horneland R, Yaqub S, Aandahl EM, Lundin KEA, Bækkevold ES, Jahnsen FL(2023) The human small intestine contains two functionally distinct regulatory T-cell subsets J Allergy Clin Immunol(in press) DOI 10.1016/j.jaci.2023.02.030, PubMed 36893861
Zhang D, Harris HM, Chen J, Judy J, James G, Kelly A, McIntosh J, Tenn-McClellan A, Ambing E, Tan YS, Lu H, Gajewski S, Clifton MC, Yung S, Robbins DW, Pirooznia M, Skånland SS, Gaglione E, Mhibik M, Underbayev C, Ahn IE, Sun C, Herman SEM, Noviski M, Wiestner A(2023) NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts Blood, 141(13), 1584-1596 DOI 10.1182/blood.2022016934, PubMed 36375120
Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT(2023) Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia Nat Commun, 14(1), 1767 DOI 10.1038/s41467-023-37488-8, PubMed 36997540
Haroun-Izquierdo A, Lanuza PM, Pfefferle A, Netskar H, Ask EH, Törlén J, Björklund A, Sohlberg E, Malmberg KJ(2023) Effect of mTOR inhibition with sirolimus on natural killer cell reconstitution in allogeneic stem cell transplantation Transplant Cell Ther(in press) DOI 10.1016/j.jtct.2023.03.023, PubMed 36966873
